A closer look inside Korea’s vaccine training center

A closer look inside Korea’s vaccine training center

Trainees participate in a hands-on session of a vaccine bio-manufacturing course organized by the Asia Development Bank and the E-Asia and Knowledge Partnership Fund (EAKPF) at Yonsei University International Campus, located in Songdo, Incheon, July 21. Korea Times photo by Lee Hyo-jin

Trainees from developing countries invited for 8-week vaccine manufacturing course

By Lee Hyo-jin

Songdo, INCHEON-The unprecedented COVID-19 pandemic highlights the importance of local manufacturing infrastructure for medical devices and vaccines, and scientists say new zoonosis in the ongoing climate change and urbanization. He expressed concern about the increasing threat of infectious diseases.

In particular, many low- and middle-income countries (LMICs) that did not have timely access to vaccines have their local manufacturing capacity to ensure a sustainable and predictable supply of vaccines, as well as current pandemics. Recognizes the need to build. , Not only for future outbreaks.

However, one of the major obstacles they face in promoting local vaccine production is the lack of skilled workers.
Against this background, South Korea, a leading bio pharmacy manufacturer, is participating in an international initiative to help these countries promote biopharmaceutical professionals.

Trainees participate in a hands-on session of the vaccine bio-manufacturing course at the Korea National Institute for Bioprocessing Research and Training (K-NIBRT) center at Yonsei University International Campus in Songdo, Incheon, July 21. Korea Times photo by Lee Hyo-jin

After being designated as a Global Center for Vaccine Training by the World Health Organization (WHO) in early February, the Government of South Korea has started several training courses in collaboration with international organizations.

One of these courses is currently being held at the Korea National Institute of Bioprocessing (K-NIBRT) Center on the international campus of Yonsei University in Incheon, about 40 km west of Seoul.

K-NIBRT is the Korean version of the National Institute for Bioprocessing (NIBRT), a leading Irish-based bio pharmacy manufacturing training and education curriculum.

Funding of the E-Asia and Knowledge Partnership Fund (EAKPF), a trust fund initiated by the Asian Development Bank (ADB) and the Korean government, 30 from 12 different Asian countries including Bangladesh, Indonesia, Cambodia, Mongolia, and Uzbekistan. Human Trainee Vietnam arrived in early June and participated in an 8-week vaccine manufacturing training course.

On July 21, at a newly constructed training facility in Matsushima, 12 trainees in white lab coats were seen enthusiastically gathering around a large stainless steel fermenter in the laboratory. In another lab across the corridor, another group of trainees was testing a vaccine they had created to confirm its purity.

‘All sessions are conducted in English, so trainees were selected based on academic or professional qualifications and knowledge of English. He is a talented person nominated by his government. ”

During the first three weeks, participants received instructive training to provide a basic understanding of all major vaccine processes, including protein subunit vaccines, vector vaccines, and mRNA vaccines.

Trainees participate in a practical session of the vaccine bio-manufacturing course at the Korea National Institute for Bioprocessing Research and Training (K-NIBRT) center at Yonsei University International Campus in Songdo, Incheon, July 21. Korea Times photo by Lee Hyo-jin

“And after completing three weeks of theoretical training, we started a five-week practice from fermentation to auxiliaries and packaging. The lab courses are primarily used for the production of other biologics.

We are focusing on the mRNA vaccine, which is a platform that can be used. ” We hope that this program will allow trainees to grow into professionals who can be quickly deployed to vaccine manufacturing sites in their home country, “she said.

Ready to contribute to vaccine production in home countries

The trainees did not seem to find the eight-week intensive course at all difficult. Instead, they wanted to make the most of it and bring the skills and knowledge they learned here back to their home countries.

“I will use the knowledge and skills I have learned here to enhance vaccine production in my country,” Mayan Lemandas, a Filipino doctor specializing in pediatric infectious diseases, told reporters.

“Currently, the Institute of Tropical Medicine I work for is making antidotes for snakebites that must be species-specific, so I started reviewing the current process for making antidotes and improving the process. We’ll see how we can apply what we’ve learned from the course to do that, “she explained.

“Next, we will also consider how to start production of other vaccines such as COVID-19, hexavalent and pneumococcal vaccines.”

Muhammed Shahabdin, who works for a state-owned pharmaceutical company in Bangladesh, vaccinated his country. I talked about the low rate.

“Our country is suffering from a pandemic because the vaccine was not in time. Not because we didn’t have the money, but because we didn’t have the vaccine pharmacy industry. We still import vaccines from abroad. “I will,” he says.

Shahabuddin found it very useful to learn about formulation development, as the training course included not only theoretical training but also hands-on training and visits to local organic producers.

“Recognizing the importance of establishing local bioproduction of vaccines to prevent the next pandemic, our government has begun the development of local vaccine manufacturers. Microbiology at the Uzbekistan Advanced Technology Center “Production experience,” said scholarly researcher Mzafer Muminov.

In that sense, he said, the training courses offered by the Korean government are a great opportunity. To establish the technology that will contribute to the production of vaccines in Uzbekistan and the further development of this field, and to share my experience and knowledge with the scientific community, “Muminov added.


Credit/Source : https://www.koreatimes.co.kr/www/nation/2022/07/119_333211.html


About kissasian

Leave a Reply